2019
DOI: 10.1101/698902
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Deep Learning for Alzheimer’s Disease: Mapping Large-scale Histological Tau Protein for Neuroimaging Biomarker Validation

Abstract: Deposits of abnormal tau protein inclusions in the brain are one of the pathological hallmarks of Alzheimer's disease (AD) and are the best predictor of neuronal loss and clinical decline. As such, imaging-based biomarkers to detect tau deposits in-vivo could leverage AD diagnosis and monitoring from earlier disease stages. Although several PET-based tau tracers are available for research studies, validation of such tracers against direct detection of tau deposits in brain tissue remain unresolved. Large-scale… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 49 publications
0
8
0
Order By: Relevance
“…To our knowledge, this work is the first to perform 3D mapping of tau NFT pathology in a sizable collection of human brain specimens ( n = 18). In a recent preprint, Alegro et al [4] describe a pioneering pipeline for 3D tau density maps generation in whole brains and present results for two brain specimens. They use deep learning to extract and quantify tau inclusions from anti-tau immunohistochemistry slides and use registration to ex vivo MRI to reconstruct 3D maps.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…To our knowledge, this work is the first to perform 3D mapping of tau NFT pathology in a sizable collection of human brain specimens ( n = 18). In a recent preprint, Alegro et al [4] describe a pioneering pipeline for 3D tau density maps generation in whole brains and present results for two brain specimens. They use deep learning to extract and quantify tau inclusions from anti-tau immunohistochemistry slides and use registration to ex vivo MRI to reconstruct 3D maps.…”
Section: Discussionmentioning
confidence: 99%
“…They use deep learning to extract and quantify tau inclusions from anti-tau immunohistochemistry slides and use registration to ex vivo MRI to reconstruct 3D maps. Alegro et al [4] perform ex vivo MRI and CT in situ , an advantage over the current work since this approach eliminates MRI artifacts due to air bubbles and makes co-registration with in vivo MRI simpler. However, in situ scanning is not always feasible to integrate into existing autopsy protocols, including at the brain banks used in our study.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations